Similar articles

• Vulvovaginal candidiasis from non-albicans species: retrospective study of recurrence rate after fluconazole therapy.

  Ventolini G, Baggish MS, Walsh PM. Ventolini G, et al. J Reprod Med. 2006 Jun;51(6):475-8. J Reprod Med. 2006. PMID: 16846086
• Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.

  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, Sperling M, Livengood C 3rd, Horowitz B, Von Thron J, Edwards L, Panzer H, Chu TC. Sobel JD, et al. N Engl J Med. 2004 Aug 26;351(9):876-83. doi: 10.1056/NEJMoa033114. N Engl J Med. 2004. PMID: 15329425 Clinical Trial.
• Elevated nitric oxide in recurrent vulvovaginal candidiasis - association with clinical findings.

  Alvendal C, Ehrström S, Brauner A, Lundberg JO, Bohm-Starke N. Alvendal C, et al. Acta Obstet Gynecol Scand. 2017 Mar;96(3):295-301. doi: 10.1111/aogs.13093. Acta Obstet Gynecol Scand. 2017. PMID: 28052314
• Is there a role for fluconazole in the treatment of vulvovaginal candidiasis?

  Patel HS, Peters MD 2nd, Smith CL. Patel HS, et al. Ann Pharmacother. 1992 Mar;26(3):350-3. doi: 10.1177/106002809202600309. Ann Pharmacother. 1992. PMID: 1554957 Review.
• Fluconazole for the treatment of candidiasis: 15 years experience.

  Cha R, Sobel JD. Cha R, et al. Expert Rev Anti Infect Ther. 2004 Jun;2(3):357-66. doi: 10.1586/14787210.2.3.357. Expert Rev Anti Infect Ther. 2004. PMID: 15482201 Review.